Clinical trial · Interventional
Bowel Preparation Regimen for Colon Capsule Endoscopy Procedure
Optimization of the Bowel Preparation Regimen for Colon Capsule Endoscopy Procedure
NCT05726097CI-TRIAL-00074517completedPhase 3ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The study aims to investigate the effect of the optimized bowel preparation and boost regimens on colon capsule endoscopy procedures, specifically on cleanliness and completion rate.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colon Cancer | Malignant Colon Neoplasm | CURATED_EXACT | 0.92 |
| Colon Polyp | — | UNRESOLVED | — |
| Gastrointestinal Bleed | — | UNRESOLVED | — |
| Inflammatory Bowel Diseases | — | UNRESOLVED | — |
Interventions
Interventions (6)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| gastrografin | Drug | — | UNRESOLVED |
| magnesiumoxid + sodium picosulfate | Drug | — | UNRESOLVED |
| polyethylene glycol | Drug | — | UNRESOLVED |
| polyethylene glycol + ascorbic acid | Drug | — | UNRESOLVED |
| prucalopride | Drug | — | UNRESOLVED |
| sodium phosphate | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- ACTIVE_COMPARATOR
- label
- Standard preparation regimen
- description
- 4 L polyethylene glycol as laxative 30 + 15 mL sodium phosphate as a booster
- interventionNames
- Drug: polyethylene glycol
- Drug: sodium phosphate
- type
- EXPERIMENTAL
- label
- Optimized preparation regimen
- description
- 1 L polyethylene glycol + ascorbic acid as laxative and gastrografin and magnesiumoxid + sodium picosulfate as a booster
- interventionNames
- Drug: polyethylene glycol + ascorbic acid
- Drug: gastrografin
- Drug: magnesiumoxid + sodium picosulfate
- type
- EXPERIMENTAL
- label
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Subject referred for clinical colon/panenteric examination * Subject received an explanation about the nature of the study and agreed to provide written informed consent Exclusion Criteria: * Subject with dysphagia or any swallowing disorder * Subject with a prior stomach, small bowel, or colonic resection * Subject with severe renal insufficiency * Subject with any allergy or other known contraindication to the medications used in the study * Women who are either pregnant or nursing * Subject suffers from life threatening conditions
References
Publications (0)
Data not yet available
No reference posted for this study.